Krystle N Agans

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Induced Pluripotent Stem Cells

Immune Response

Monoclonal Antibody

Top Venues

Science translational medicine

Scientific reports

Proceedings of the National Academy of Sciences of the United States of America

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Larry Zeitlin, Robert W Cross, Courtney Woolsey, Brandyn R West, Viktoriya Borisevich, Krystle N Agans, Abhishek N Prasad, Daniel J Deer, Lauren Stuart, Maria McCavitt-Malvido, Do H Kim, James Pettitt, James E Crowe, Kevin J Whaley, David J Veesler, Antony S Dimitrov, Dafna M Abelson, Thomas W Geisbert, Christopher C Broder
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates. Science translational medicine 16 (741) (2024)
Robert W Cross, Courtney Woolsey, Victor C Chu, Darius Babusis, Roy Bannister, Meghan S Vermillion, Romas Geleziunas, Kimberly T Barrett, Elaine Bunyan, Anh-Quan Nguyen, Tomas Cihlar, Danielle P Porter, Abhishek N Prasad, Daniel J Deer, Viktoriya Borisevich, Krystle N Agans, Jasmine Martinez, Mack B Harrison, Natalie S Dobias, Karla A Fenton, John P Bilello, Thomas W Geisbert
Oral administration of obeldesivir protects nonhuman primates against Sudan ebolavirus . Science (New York, N.Y.) 383 (6688) (2024)
Robert W Cross, Courtney Woolsey, Victor C Chu, Darius Babusis, Roy Bannister, Meghan S Vermillion, Romas Geleziunas, Kimberly T Barrett, Elaine Bunyan, Anh-Quan Nguyen, Tomas Cihlar, Danielle P Porter, Abhishek N Prasad, Daniel J Deer, Viktoriya Borisevich, Krystle N Agans, Jasmine Martinez, Mack B Harrison, Natalie S Dobias, Karla A Fenton, John P Bilello, Thomas W Geisbert
Oral administration of obeldesivir protects nonhuman primates against Sudan ebolavirus . Science (New York, N.Y.) 383 (6688) (2024)
Larry Zeitlin, Robert W Cross, Courtney Woolsey, Brandyn R West, Viktoriya Borisevich, Krystle N Agans, Abhishek N Prasad, Daniel J Deer, Lauren Stuart, Maria McCavitt-Malvido, Do H Kim, James Pettitt, James E Crowe, Kevin J Whaley, David J Veesler, Antony S Dimitrov, Dafna M Abelson, Thomas W Geisbert, Christopher C Broder
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates. Science translational medicine 16 (741) (2024)
Robert W Cross, Courtney Woolsey, Victor C Chu, Darius Babusis, Roy Bannister, Meghan S Vermillion, Romas Geleziunas, Kimberly T Barrett, Elaine Bunyan, Anh-Quan Nguyen, Tomas Cihlar, Danielle P Porter, Abhishek N Prasad, Daniel J Deer, Viktoriya Borisevich, Krystle N Agans, Jasmine Martinez, Mack B Harrison, Natalie S Dobias, Karla A Fenton, John P Bilello, Thomas W Geisbert
Oral administration of obeldesivir protects nonhuman primates against Sudan ebolavirus . Science (New York, N.Y.) 383 (6688) (2024)
Larry Zeitlin, Robert W Cross, Courtney Woolsey, Brandyn R West, Viktoriya Borisevich, Krystle N Agans, Abhishek N Prasad, Daniel J Deer, Lauren Stuart, Maria McCavitt-Malvido, Do H Kim, James Pettitt, James E Crowe, Kevin J Whaley, David J Veesler, Antony S Dimitrov, Dafna M Abelson, Thomas W Geisbert, Christopher C Broder
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates. Science translational medicine 16 (741) (2024)
Robert W Cross, Megan L Heinrich, Karla A Fenton, Viktoriya Borisevich, Krystle N Agans, Abhishek N Prasad, Courtney Woolsey, Daniel J Deer, Natalie S Dobias, Megan M Rowland, Raju Lathigra, Rodrigo Borrega, Joan B Geisbert, Robert F Garry, Luis M Branco, Thomas W Geisbert
A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus. Proceedings of the National Academy of Sciences of the United States of America 120 (34) (2023)
Ruth Hunegnaw, Anna N Honko, Lingshu Wang, Derick Carr, Tamar Murray, Wei Shi, Lam Nguyen, Nadia Storm, Caitlyn N M Dulan, Kathryn E Foulds, Krystle N Agans, Robert W Cross, Joan B Geisbert, Cheng Cheng, Aurélie Ploquin, Daphne A Stanley, Thomas W Geisbert, Gary J Nabel, Nancy J Sullivan
A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates. Science translational medicine 14 (675) (2022)
Ruth Hunegnaw, Anna N Honko, Lingshu Wang, Derick Carr, Tamar Murray, Wei Shi, Lam Nguyen, Nadia Storm, Caitlyn N M Dulan, Kathryn E Foulds, Krystle N Agans, Robert W Cross, Joan B Geisbert, Cheng Cheng, Aurélie Ploquin, Daphne A Stanley, Thomas W Geisbert, Gary J Nabel, Nancy J Sullivan
A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates. Science translational medicine 14 (675) (2022)
Courtney Woolsey, Alyssa C Fears, Viktoriya Borisevich, Krystle N Agans, Natalie S Dobias, Abhishek N Prasad, Daniel J Deer, Joan B Geisbert, Karla A Fenton, Thomas W Geisbert, Robert W Cross
Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques. Emerging microbes & infections 11 (1) (2022)
Ruth Hunegnaw, Anna N Honko, Lingshu Wang, Derick Carr, Tamar Murray, Wei Shi, Lam Nguyen, Nadia Storm, Caitlyn N M Dulan, Kathryn E Foulds, Krystle N Agans, Robert W Cross, Joan B Geisbert, Cheng Cheng, Aurélie Ploquin, Daphne A Stanley, Thomas W Geisbert, Gary J Nabel, Nancy J Sullivan
A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates. Science translational medicine 14 (675) (2022)
Stephanie L Foster, Courtney Woolsey, Viktoriya Borisevich, Krystle N Agans, Abhishek N Prasad, Daniel J Deer, Joan B Geisbert, Natalie S Dobias, Karla A Fenton, Robert W Cross, Thomas W Geisbert
A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease. Proceedings of the National Academy of Sciences of the United States of America 119 (12) (2022)
Larry Zeitlin, Robert W Cross, Joan B Geisbert, Viktoriya Borisevich, Krystle N Agans, Abhishek N Prasad, Sven Enterlein, M Javad Aman, Zachary A Bornholdt, Miles B Brennan, Lioudmila Campbell, Do Kim, Neil Mlakar, Crystal L Moyer, Michael H Pauly, William Shestowsky, Kevin J Whaley, Karla A Fenton, Thomas W Geisbert
Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody. Proceedings of the National Academy of Sciences of the United States of America 118 (11) (2021)
Robert W Cross, Zachary A Bornholdt, Abhishek N Prasad, Viktoriya Borisevich, Krystle N Agans, Daniel J Deer, Dafna M Abelson, Do H Kim, William S Shestowsky, Lioudmila A Campbell, Elaine Bunyan, Joan B Geisbert, Karla A Fenton, Larry Zeitlin, Danielle P Porter, Thomas W Geisbert
Combination therapy protects macaques against advanced Marburg virus disease. Nature communications 12 (1) (2021)
Robert W Cross, Zachary A Bornholdt, Abhishek N Prasad, Joan B Geisbert, Viktoriya Borisevich, Krystle N Agans, Daniel J Deer, Kevin Melody, Karla A Fenton, Heinrich Feldmann, Armand Sprecher, Larry Zeitlin, Thomas W Geisbert
Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment. Nature communications 11 (1) (2020)
Courtney Woolsey, Allen Jankeel, Demetrius Matassov, Joan B Geisbert, Krystle N Agans, Viktoriya Borisevich, Robert W Cross, Daniel J Deer, Karla A Fenton, Theresa E Latham, Cheryl S Gerardi, Chad E Mire, John H Eldridge, Ilhem Messaoudi, Thomas W Geisbert
Immune correlates of postexposure vaccine protection against Marburg virus. Scientific reports 10 (1) (2020)
Hadas Cohen-Dvashi, Ron Amon, Krystle N Agans, Robert W Cross, Aliza Borenstein-Katz, Mathieu Mateo, Sylvain Baize, Vered Padler-Karavani, Thomas W Geisbert, Ron Diskin
Rational design of universal immunotherapy for TfR1-tropic arenaviruses. Nature communications 11 (1) (2020)
Krista Versteeg, Andrea R Menicucci, Courtney Woolsey, Chad E Mire, Joan B Geisbert, Robert W Cross, Krystle N Agans, Daniel Jeske, Ilhem Messaoudi, Thomas W Geisbert
Author Correction: Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants. Scientific reports 9 (1) (2019)
Benjamin A Satterfield, Viktoriya Borisevich, Stephanie L Foster, Sergio E Rodriguez, Robert W Cross, Karla A Fenton, Krystle N Agans, Christopher F Basler, Thomas W Geisbert, Chad E Mire
Antagonism of STAT1 by Nipah virus P gene products modulates disease course but not lethal outcome in the ferret model. Scientific reports 9 (1) (2019)
Chad E Mire, Robert W Cross, Joan B Geisbert, Viktoriya Borisevich, Krystle N Agans, Daniel J Deer, Megan L Heinrich, Megan M Rowland, Augustine Goba, Mambu Momoh, Mathew L Boisen, Donald S Grant, Mohamed Fullah, Sheik Humarr Khan, Karla A Fenton, James E Robinson, Luis M Branco, Robert F Garry, Thomas W Geisbert
Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever. Nature medicine 23 (10) (2017)
Krista Versteeg, Andrea R Menicucci, Courtney Woolsey, Chad E Mire, Joan B Geisbert, Robert W Cross, Krystle N Agans, Daniel Jeske, Ilhem Messaoudi, Thomas W Geisbert
Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants. Scientific reports 7 (1) (2017)